MCM3AP-AS1, another essential cancer-related lncRNA, has been identified as part of a metabolism-related lncRNA signature that can predict outcomes in COAD patients, potentially aiding in personalized prevention and treatment strategies [38]. Here, MCM3AP is linked to colon adenocarcinoma.